"Slagelse Sygehus er et af fire sygehuse i Region Sjælland, som har en akutafdeling, der er specialiseret i hurtig behandling af akut opstående sygdomme."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Slagelse Hospital
5
Herlev Hospital
3
Naestved Hospital
2
Pfizer
2
Scandinavian Critical Care Trials Group
2
University of Southern Denmark
2
Zealand University Hospital
2
AM-Pharma
1
Amgen
1
Anders Perner
1
Boehringer Ingelheim
1
Clinical Trials at Slagelse Hospital
During the past decade, Slagelse Hospital conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 3 clinical trials were completed, i.e. on
average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 1 clinical trials were completed. i.e. 6.3%
of trials that started reached the finish line.
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Slagelse Hospital" #1 sponsor was "Slagelse Hospital" with 5 trials, followed by "Herlev Hospital" with 3 trials
sponsored, "Naestved Hospital" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Scandinavian Critical Care Trials Group"
with 2 trials sponsored. Other sponsors include 15 different institutions and
companies that sponsored additional 23 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Slagelse Hospital"
#1 collaborator was "Rigshospitalet, Denmark" with 6 trials as a collaborator, "Holbaek Sygehus" with 5 trials as a collaborator, "Zealand University Hospital" with 5 trials as a collaborator, "Aarhus University Hospital" with 4 trials as a collaborator and "Copenhagen Trial Unit, Center for Clinical Intervention Research" with 4 trials as a collaborator. Other collaborators include 76 different institutions and companies that were
collaborators in the rest 66 trials.
Clinical Trials Conditions at Slagelse Hospital
According to Clinical.Site data, the most researched conditions in "Slagelse Hospital" are
"Septic Shock" (3 trials), "Aortic Aneurysm, Abdominal" (2 trials), "Arterial Occlusive Diseases" (2 trials), "Atherosclerotic Cardiovascular Disease" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Slagelse Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Slagelse Hospital
Most popular intervention types in "Slagelse Hospital" are "Drug" (12 trials), "Other" (6 trials), "Biological" (4 trials), "Procedure" (4 trials) and "Behavioral" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "bococizumab (PF-04950615)" (2 trials), "6% Hydroxyethyl starch 130/0.4" (1 trials), "Arthroplasty" (1 trials) and "Arthroscopic partial meniscectomy" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Slagelse Hospital
The vast majority of trials in "Slagelse Hospital" are
34 trials for "All" genders.
Clinical Trials Status at Slagelse Hospital
Currently, there are NaN active trials in "Slagelse Hospital".
1 are not yet recruiting,
9 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in Slagelse Hospital,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Slagelse Hospital, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 11 trials that are defined as “Not Applicable".